CD4 and neoplasm: In addition, whether antigen-specific memory CD4+ T cells can prevent tumor metastasis and respond to PD-1 signaling blockade therapy has not been fully elucidated, and the possibility that CD4+ T cells can become exhausted during tumor progression remains a matter of debate.